Qiagen Teams with Max Planck on TB MDx Test | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Qiagen today said that it will collaborate with the Max Planck Institute for Infection Biology's department of immunology to develop a molecular diagnostic test for tuberculosis.

Specifically, the partners will develop a test aimed at assessing the risk of an individual with latent TB developing active TB disease during his lifetime.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: random DNA replication errors play role in cancer, and more.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.